Share on StockTwits

pSivida Corp (NASDAQ:PSDV) VP Lori Freedman sold 7,900 shares of the company’s stock on the open market in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $4.00, for a total transaction of $31,600.00. Following the transaction, the vice president now directly owns 96,423 shares of the company’s stock, valued at approximately $385,692. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

pSivida Corp (NASDAQ:PSDV) traded down 0.75% during mid-day trading on Wednesday, hitting $3.98. 38,113 shares of the company’s stock traded hands. pSivida Corp has a 52-week low of $2.28 and a 52-week high of $5.60. The stock’s 50-day moving average is $3.73 and its 200-day moving average is $3.94. The company’s market cap is $116.4 million.

pSivida Corp (NASDAQ:PSDV) last announced its earnings results on Tuesday, May 13th. The company reported ($0.03) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. On average, analysts predict that pSivida Corp will post $-0.69 earnings per share for the current fiscal year.

Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. pSivida Corp presently has a consensus rating of “Buy” and an average target price of $5.43.

pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.